ADYX Stock Analysis

Adynxx Inc

Alliqua, Inc. (Alliqua), formerly HepaLife Technologies, Inc., biomedical company. Through AquaMed, the Company develops, manufactures and markets high water content, electron beam cross-linked, aqueous polymerhydrogels (gels) used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. Through Alliqua Biomedical Inc., it focuses on the development of products for wound care dressings and a core transdermal delivery technology platform designed to deliver drugs and other beneficial ingredients through the skin. Through HepaLife Biosystems, Inc., it holds legacy technology called HepaMate. The Company supplies hydrogels primarily to the pain management segment of the healthcare industry. Its products are manufactured using mixing, coating and cross-linking technologies. It manufactures hydrogels, hydrogel patches and hydrogel products that have been used by some of the United States cosmetics companies.